Results 71 to 80 of about 182,114 (282)

Treatment of the Spasticity in Children with Cerebral Palsy

Biomolecules & Biomedicine, 2008
Botulinum toxin is a natural purified protein and one of the strongest biological poisons - neurotoxin. It is produced by the bacterium Clostridium botulinum. Its medical usage started in USA in 1981 and in Europe in 1992.
Ajša Meholjić-Fetahović
doaj   +1 more source

Comprehensive Review on Advancements in Food Preservation Technologies for Quality and Sustainability

Food Chemistry International, EarlyView.
Preservatives limit microbial development, oxidation, and enzymatic degradation, resulting in better food quality and extended shelf life. Classified as natural, synthetic, or biological, each preservative has distinctive attributes and modes of action. Growing preference for natural preservatives aligns with clean label trends.
Monica Suresh, Arun Meyyazhagan, Haripriya Kuchi Bhotla, Manikantan Pappuswamy, Balamuralikrishnan Balasubramanian   +4 more
wiley   +1 more source

Botulinum toxin application to the buccinator muscle in the treatment of facial synkinesis: a prospective cohort study

Australasian Journal of Plastic Surgery
**Background**: Synkinesis may develop following facial nerve palsy, impacting quality of life. Botulinum toxin treatment for synkinesis is commonly used, but buccinator muscle injection is less common.
Raymond Hayler, Gazi Hussain, Jonathan Clark, Susan Coulson, Tsu-Hui (Hubert) Low   +4 more
doaj   +1 more source

Botulinum Toxin in the Treatment of Lingual Dystonia Induced by Speaking

Case Reports in Neurology, 2013
Primary lingual dystonia is a rare condition, especially when it is only induced by speaking. Trihexyphenidyl failed to improve the symptoms. Several case series have demonstrated the effectiveness of botulinum toxin injection for the management of focal
F. Budak, E. Aydın, A. Koçkaya, G. Ilbay   +3 more
doaj   +1 more source

Botulinum toxin and spasticity [PDF]

Journal of Neurology, Neurosurgery & Psychiatry, 2000
The clinical effects of botulinum toxin have been recognised since the end of the 19th century. It is the most potent neurotoxin known and it is produced by the gram negative anaerobic bacterium Clostridium botulinum. The paralytic effect of the toxin is due to blockade of neuromuscular transmission.1 Injection into a muscle causes chemodenervation and
E C, Davis, M P, Barnes
openaire   +2 more sources

Uso da toxina botulínica no controle do bruxismo [PDF]

, 2014
TCC (graduação) - Universidade Federal de Santa Catarina. Centro de Ciências da Saúde. Odontologia.A toxina botulínica é uma substância produzida pela bactéria Clostridium botulinum, e o seu uso oferece ao cirurgião dentista uma nova alternativa para ...
Francescon, Ariane
core  

Postharvest Management to Preserve the Nutritional Quality of Vegetables: An Overview Based on Current Research Findings Across the Globe

Future Postharvest and Food, EarlyView.
Postharvest losses in vegetables extend beyond mere quantitative reduction through physical deterioration and spoilage; they encompass substantial qualitative degradation, particularly the deterioration of critical nutritional constituents. Following harvest, vegetables maintain metabolic activity, and when subjected to suboptimal environmental ...
Md. Abdul Kader, Kazi N. Salehin Rafi, Annika Jahan Aonti, Md. Parvez Kabir, Akbar Hossain   +4 more
wiley   +1 more source

Botulinum Toxin for First Bite Syndrome: A Symptom‐Guided “Follow‐The‐Pain” Injection Strategy

Head &Neck, EarlyView.
ABSTRACT Background To evaluate botulinum toxin type A (BoNT‐A) for First Bite Syndrome (FBS) and assess a symptom‐guided “Follow‐the‐Pain” (FTP) injection strategy in patients with incomplete response to standard treatment. Methods Consecutive patients with postoperative FBS were treated with ultrasound‐guided intraparotid BoNT‐A injection.
Rosario Marchese‐Ragona, Gianmarco Giunta, Daniela Adamo, Elisabetta Zanoletti, Daniele Manfredini, Domenico Antonio Restivo   +5 more
wiley   +1 more source

Expert consensus on neuro‐musculoskeletal functional reconstruction for post‐stroke spastic hemiplegia

Ibrain, EarlyView.
This expert consensus proposes a patient‐centered pathway for functional reconstruction after post‐stroke spastic hemiplegia: “patient goal–pathophysiologic component–treatment target–functional reassessment.” Treatment selection and sequencing across motor retraining, brain–computer interfaces, peripheral nerve surgery, and tendon/soft‐tissue ...
Peng Wen, Yihe Wang, Zhongzheng He, Zhizhong Zhu, Chunbing Chen, Kaifeng Wu, Xiaohong Fu, Guoguang Zhao, Liulin Xiong, “Zunyi Brain‐Computer Interface Medical Center” Working Group, Denggui Cheng, Zhaojian Deng, Min Gong, Chong Han, Qijun Jiang, Hang Li, Jianping Li, Shun Li, Yu Li, Minjie Luo, Chiyuan Ma, Yongzhi Shan, Jun Wang, Nana Wang, Qinglan Wang, Ziheng Wang, Zhongying Wei, Guojun Wu, Bo Xiong, Jianguo Xu, Minpeng Xu, Kaihua Yang, Xi Yang, Fan Zhang, Hongtian Zhang, Jing Zhang, Shaofu Zhang, Hongxin Zhao, Min Zhao, Mingjiang Zhu   +39 more
wiley   +1 more source

BOTOX injection to treat strabismus after infant botulism type B infection

American Journal of Ophthalmology Case Reports, 2020
Purpose: The significance of botulinum toxin to ophthalmologists is twofold. Botulism, a medical emergency, frequently presents with ocular findings including blurred vision, diplopia, ptosis, and photophobia as a result of the neurotoxin produced by ...
Sarah G. Bonaffini, Victoria Cocozza, Jing Jin   +2 more
doaj   +1 more source